308 related articles for article (PubMed ID: 12910723)
1. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
2. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
[TBL] [Abstract][Full Text] [Related]
4. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
6. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
8. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
Liang W; Chen S; Xing F
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
Zhou C; Yu C; Zhuang G
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
[TBL] [Abstract][Full Text] [Related]
11. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.
Kosaka K; Fujiwara H; Yoshioka S; Fujii S
Hum Reprod; 2007 Jun; 22(6):1647-51. PubMed ID: 17356124
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
[TBL] [Abstract][Full Text] [Related]
14. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
15. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
16. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
Gómez R; Lima I; Simón C; Pellicer A
Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
[TBL] [Abstract][Full Text] [Related]
19. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
20. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]